JME
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Molecular Endocrinology (2009) 42 449-459    DOI: 10.1677/JME-08-0144
© 2009 Society for Endocrinology

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
JME-08-0144v1
42/6/449    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rickard, A. J
Right arrow Articles by Young, M. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rickard, A. J
Right arrow Articles by Young, M. J

Review

Corticosteroid receptors, macrophages and cardiovascular disease

Amanda J Rickard1,2 and Morag J Young1,2

1 Prince Henry's Institute of Medical Research, Clayton, 3168 Victoria, Australia2 Department of Physiology, Monash University, Clayton, 3800 Victoria, Australia

(Correspondence should be addressed to A J Rickard; Email: amanda.rickard{at}princehenrys.org)

The mineralocorticoid receptor (MR) and glucocorticoid receptor are ligand-activated transcription factors that have important physiological and pathophysiological actions in a broad range of cell types including monocytes and macrophages. While the glucocorticoids cortisol and corticosterone have well-described anti-inflammatory actions on both recruited and tissue resident macrophages, a role for the mineralocorticoid aldosterone in these cells is largely undefined. Emerging evidence, however, suggests that MR signalling may promote pro-inflammatory effects. This review will discuss the current understanding of the role of corticosteroid receptors in macrophages and their effect on diseases involving inflammation, with a particular focus on cardiovascular disease.




This article has been cited by other articles:


Home page
HypertensionHome page
A. Bergmann, C. Eulenberg, M. Wellner, S. Rolle, F. Luft, and R. Kettritz
Aldosterone Abrogates Nuclear Factor {kappa}B-Mediated Tumor Necrosis Factor {alpha} Production in Human Neutrophils via the Mineralocorticoid Receptor
Hypertension, February 1, 2010; 55(2): 370 - 379.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
N. A. Guagliardo, K. N. West, L. P. McCluskey, and D. L. Hill
Attenuation of peripheral salt taste responses and local immune function contralateral to gustatory nerve injury: effects of aldosterone
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2009; 297(4): R1103 - R1110.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. Carlson, W. Cui, Q. Zhang, X. Xu, F. Mercan, A. M. Bennett, and A. Vignery
Role of MKP-1 in Osteoclasts and Bone Homeostasis
Am. J. Pathol., October 1, 2009; 175(4): 1564 - 1573.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the Society for Endocrinology.